Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046709 · ClinicalTrials.gov registry record · Phase 1
Marijuana for Cancer Pain
A Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00046709: Clinical Trial Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
NCT00046709 is a Phase 1 study that was terminated before completion, run by Center for Medicinal Cannabis Research. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00046709, a Phase 1 study, was terminated before completion, sponsored by Center for Medicinal Cannabis Research.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.
Interventions
- DRUG Smoked Marijuana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2002-09 |
| Est. Completion | 2004-10 |
| Phase | Phase 1 |
Why NCT00046709 stopped before completion
NCT00046709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which Smoked Marijuana is the first listed.
NCT00046709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00046709 about?
NCT00046709 is a clinical study titled "Marijuana for Cancer Pain". To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include n...
What is the current status of trial NCT00046709?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2002-09. Estimated completion is 2004-10.
What interventions are being tested in trial NCT00046709?
The interventions under investigation include: Smoked Marijuana (DRUG).
Who is sponsoring clinical trial NCT00046709?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00046709's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia